Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IVA Inventiva S.A.

交易中 05-20 10:50:13 EDT

3.82

+0.02

+0.53%

最高3.88	最低3.80	成交量2,314
今开3.88	昨收3.80	日振幅2.11%
总市值2.00亿	流通市值5,965万	总股本5,237万
成交额8,842	换手率0.01%	流通股本1,561万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IVA","market":"US","secType":"STK","nameCN":"Inventiva S.A.","latestPrice":3.82,"timestamp":1716216528389,"preClose":3.8,"halted":0,"volume":2314,"delay":0,"floatShares":15614393,"shares":52371073,"eps":-2.691362,"marketStatus":"交易中","marketStatusCode":2,"change":0.02,"latestTime":"05-20 10:50:13 EDT","open":3.88,"high":3.88,"low":3.8,"amount":8841.7632238,"amplitude":0.021053,"askPrice":3.83,"askSize":100,"bidPrice":3.79,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.691362,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1716235200000},"adr":0,"listingDate":1594353600000,"adjPreClose":3.8,"adrRate":1,"preHourTrading":{"tag":"盘前","latestPrice":3.7,"preClose":3.8,"latestTime":"09:18 EDT","volume":40,"amount":148,"timestamp":1716211121072},"volumeRatio":1.70552},"requestUrl":"/m/hq/s/IVA/","defaultTab":"news","newsList":[{"id":"2435159371","title":"Inventiva Sa盘中异动 股价大涨6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2435159371","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2435159371?lang=zh_cn&edition=full","pubTime":"2024-05-13 22:50","pubTimestamp":1715611822,"startTime":"0","endTime":"0","summary":"北京时间2024年05月13日22时50分，Inventiva Sa股票出现波动，股价快速拉升6.51%。截至发稿，该股报3.60美元/股，成交量4077股，换手率0.01%，振幅5.03%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.21%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051322502387e878d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051322502387e878d9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434860497","title":"Inventiva Sa盘中异动 股价大跌5.24%报3.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434860497","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434860497?lang=zh_cn&edition=full","pubTime":"2024-05-11 02:19","pubTimestamp":1715365151,"startTime":"0","endTime":"0","summary":"北京时间2024年05月11日02时19分，Inventiva Sa股票出现异动，股价大幅下挫5.24%。截至发稿，该股报3.25美元/股，成交量4587股，换手率0.01%，振幅2.25%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.14%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051102191187e872d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051102191187e872d9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433476451","title":"Inventiva Sa盘中异动 早盘快速上涨7.58%报3.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2433476451","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433476451?lang=zh_cn&edition=full","pubTime":"2024-05-06 21:30","pubTimestamp":1715002237,"startTime":"0","endTime":"0","summary":"北京时间2024年05月06日21时30分，Inventiva Sa股票出现波动，股价大幅上涨7.58%。截至发稿，该股报3.55美元/股，成交量1262股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.00%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506213037861eb2b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240506213037861eb2b5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432715634","title":"Inventiva Sa盘中异动 临近收盘大幅拉升5.54%报3.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432715634","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432715634?lang=zh_cn&edition=full","pubTime":"2024-05-02 03:52","pubTimestamp":1714593130,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日03时52分，Inventiva Sa股票出现波动，股价快速上涨5.54%。截至发稿，该股报3.24美元/股，成交量5972股，换手率0.01%，振幅4.23%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为1.80%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502035210861ea97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502035210861ea97c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431732696","title":"Inventiva Sa盘中异动 早盘急速下跌5.56%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431732696","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431732696?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:31","pubTimestamp":1714483899,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时31分，Inventiva Sa股票出现异动，股价快速下挫5.56%。截至发稿，该股报3.06美元/股，成交量2000股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.05%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021313987c3f57e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021313987c3f57e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431861710","title":"Inventiva Sa盘中异动 早盘股价大跌5.85%报3.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431861710","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431861710?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:56","pubTimestamp":1714398970,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时56分，Inventiva Sa股票出现异动，股价大幅下挫5.85%。截至发稿，该股报3.06美元/股，成交量3271股，换手率0.01%，振幅5.23%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.74%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921561087e84c09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921561087e84c09&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428660992","title":"Inventiva Sa盘中异动 急速下挫5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428660992","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428660992?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:24","pubTimestamp":1713551052,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时24分，Inventiva Sa股票出现异动，股价急速下挫5.21%。截至发稿，该股报3.27美元/股，成交量5916股，换手率0.01%，振幅3.19%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.02%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420022413861e781d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420022413861e781d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428592453","title":"Inventiva Sa盘中异动 快速上涨6.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428592453","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428592453?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:03","pubTimestamp":1713449035,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日22时03分，Inventiva Sa股票出现异动，股价急速上涨6.83%。截至发稿，该股报3.44美元/股，成交量2700股，换手率0.01%，振幅3.11%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.47%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。该公司的所有业务均在法国进行。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182203557a53cbe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404182203557a53cbe7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427886668","title":"Inventiva Sa盘中异动 急速下跌5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427886668","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427886668?lang=zh_cn&edition=full","pubTime":"2024-04-16 00:29","pubTimestamp":1713198578,"startTime":"0","endTime":"0","summary":"北京时间2024年04月16日00时29分，Inventiva Sa股票出现波动，股价快速跳水5.35%。截至发稿，该股报3.36美元/股，成交量5.3776万股，换手率0.10%，振幅5.35%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.33%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160029387a52e028&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404160029387a52e028&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425957929","title":"加拿大投资银行集团：维持Inventiva(IVA.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2425957929","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2425957929?lang=zh_cn&edition=full","pubTime":"2024-04-08 19:55","pubTimestamp":1712577358,"startTime":"0","endTime":"0","summary":"加拿大投资银行集团：维持Inventiva(IVA.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040819561087545285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024040819561087545285&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421135772","title":"Inventiva Sa盘中异动 下午盘股价大涨5.80%","url":"https://stock-news.laohu8.com/highlight/detail?id=2421135772","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421135772?lang=zh_cn&edition=full","pubTime":"2024-03-21 02:39","pubTimestamp":1710959982,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日02时39分，Inventiva Sa股票出现波动，股价快速上涨5.80%。截至发稿，该股报3.65美元/股，成交量4.637万股，换手率0.09%，振幅8.41%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.53%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032102394287e7a721&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032102394287e7a721&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420227676","title":"Inventiva Sa盘中异动 股价大跌9.40%报3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420227676","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420227676?lang=zh_cn&edition=full","pubTime":"2024-03-19 21:31","pubTimestamp":1710855107,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日21时31分，Inventiva Sa股票出现异动，股价快速下挫9.40%。截至发稿，该股报3.95美元/股，成交量2.6865万股，换手率0.05%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.05%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192131478b4801cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403192131478b4801cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420284613","title":"Inventiva Sa盘中异动 下午盘快速拉升5.00%报4.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420284613","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420284613?lang=zh_cn&edition=full","pubTime":"2024-03-19 03:28","pubTimestamp":1710790118,"startTime":"0","endTime":"0","summary":"北京时间2024年03月19日03时28分，Inventiva Sa股票出现波动，股价快速拉升5.00%。截至发稿，该股报4.41美元/股，成交量12.0324万股，换手率0.23%，振幅5.48%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.21%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190328387a4d743e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403190328387a4d743e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419189073","title":"Inventiva Sa盘中异动 下午盘股价大涨5.98%报4.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419189073","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419189073?lang=zh_cn&edition=full","pubTime":"2024-03-16 03:02","pubTimestamp":1710529349,"startTime":"0","endTime":"0","summary":"北京时间2024年03月16日03时02分，Inventiva Sa股票出现异动，股价快速上涨5.98%。截至发稿，该股报4.25美元/股，成交量8.5817万股，换手率0.17%，振幅3.87%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.24%。其相关个股中，杰龙、Outlook Therapeutics, Inc.、Nutriband Inc C/Wts 涨幅较大，Better Therapeutics, Inc.、Galmed Pharmaceuticals Ltd.、Jaguar Health, Inc.较为活跃，换手率分别为352.74%、81.29%、46.02%，振幅较大的相关个股有Better Therapeutics, Inc.、Nutriband Inc C/Wts 、Outlook Therapeutics, Inc.，振幅分别为150.57%、73.88%、66.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160302297a4d1ad3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403160302297a4d1ad3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417068436","title":"Inventiva Sa盘中异动 快速拉升5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2417068436","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417068436?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:54","pubTimestamp":1709909645,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时54分，Inventiva Sa股票出现异动，股价大幅拉升5.52%。截至发稿，该股报3.82美元/股，成交量1.7523万股，换手率0.03%，振幅2.08%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.21%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082254057918a703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403082254057918a703&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416462380","title":"Inventiva Sa盘中异动 早盘急速上涨5.63%报3.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416462380","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416462380?lang=zh_cn&edition=full","pubTime":"2024-03-02 00:18","pubTimestamp":1709309922,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日00时18分，Inventiva Sa股票出现波动，股价大幅上涨5.63%。截至发稿，该股报3.82美元/股，成交量5429股，换手率0.01%，振幅2.49%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为2.41%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200184279166404&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030200184279166404&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414800412","title":"Inventiva Sa盘中异动 股价大涨6.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414800412","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414800412?lang=zh_cn&edition=full","pubTime":"2024-02-28 00:48","pubTimestamp":1709052499,"startTime":"0","endTime":"0","summary":"北京时间2024年02月28日00时48分，Inventiva Sa股票出现波动，股价大幅上涨6.00%。截至发稿，该股报3.56美元/股，成交量1.6246万股，换手率0.03%，振幅4.17%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.17%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280048207a47583f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402280048207a47583f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413476120","title":"Inventiva Sa盘中异动 早盘快速下跌5.15%报3.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2413476120","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413476120?lang=zh_cn&edition=full","pubTime":"2024-02-23 22:32","pubTimestamp":1708698746,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日22时32分，Inventiva Sa股票出现波动，股价急速下挫5.15%。截至发稿，该股报3.22美元/股，成交量1007股，换手率0.00%，振幅0.00%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为0.50%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322322687b5bdde&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022322322687b5bdde&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413240234","title":"Inventiva Sa盘中异动 大幅拉升5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413240234","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413240234?lang=zh_cn&edition=full","pubTime":"2024-02-23 02:55","pubTimestamp":1708628121,"startTime":"0","endTime":"0","summary":"北京时间2024年02月23日02时55分，Inventiva Sa股票出现异动，股价大幅拉升5.09%。Inventiva Sa股票所在的生物技术行业中，整体涨幅为2.25%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。该公司专注于开发其候选产品 lanifibranor，用于治疗非酒精性脂肪性肝炎或 NASH 患者，这种疾病目前尚无批准的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022302552187e724fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022302552187e724fc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411665259","title":"Inventiva Sa股价重挫16.97% 市值跌2867.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411665259","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411665259?lang=zh_cn&edition=full","pubTime":"2024-02-16 22:33","pubTimestamp":1708093982,"startTime":"0","endTime":"0","summary":"北京时间2024年02月16日22时33分，Inventiva Sa股票出现异动，股价大幅下挫16.97%。截至发稿，该股报3.27美元/股，成交量9209股，换手率0.02%，振幅1.75%。Inventiva Sa股票所在的生物技术行业中，整体跌幅为0.08%。Inventiva Sa公司简介：Inventiva SA 是一家总部位于法国的生物制药公司，专门开发影响核受体、转录因子和表观遗传调节的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021622330287975249&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024021622330287975249&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://inventivapharma.com","stockEarnings":[{"period":"1week","weight":0.1225},{"period":"1month","weight":0.1783},{"period":"3month","weight":0.1463},{"period":"6month","weight":-0.037},{"period":"1year","weight":0.4},{"period":"ytd","weight":-0.1599}],"compareEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":0.0577},{"period":"3month","weight":0.0599},{"period":"6month","weight":0.1745},{"period":"1year","weight":0.2629},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Inventiva S.A.成立于2011年，并于2016年注册成立。该公司是一家临床阶段的生物制药公司，致力于开发口服小分子疗法，以治疗非酒精性脂肪性肝炎或NASH，粘多糖酶或MPS以及其他未满足医疗需求的严重疾病。该公司建立了一个由发现引擎支持的管道，该发现引擎具有广泛的专有分子库，一个全资研发设施以及一个在开发针对核受体，转录因子和表观遗传调控的化合物方面拥有丰富专业知识和经验的团队。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.033773},{"month":2,"riseRate":0.5,"avgChangeRate":-0.02424},{"month":3,"riseRate":0,"avgChangeRate":-0.114231},{"month":4,"riseRate":0,"avgChangeRate":-0.166714},{"month":5,"riseRate":0.75,"avgChangeRate":0.165828},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.116382},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.052},{"month":8,"riseRate":0.25,"avgChangeRate":0.014638},{"month":9,"riseRate":0.5,"avgChangeRate":0.005555},{"month":10,"riseRate":0.75,"avgChangeRate":0.065387},{"month":11,"riseRate":0.25,"avgChangeRate":-0.033954},{"month":12,"riseRate":1,"avgChangeRate":0.075845}],"exchange":"NASDAQ","name":"Inventiva S.A.","nameEN":"Inventiva S.A."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Inventiva S.A.,IVA,Inventiva S.A.股票,Inventiva S.A.股票老虎,Inventiva S.A.股票老虎国际,Inventiva S.A.行情,Inventiva S.A.股票行情,Inventiva S.A.股价,Inventiva S.A.股市,Inventiva S.A.股票价格,Inventiva S.A.股票交易,Inventiva S.A.股票购买,Inventiva S.A.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Inventiva S.A.(IVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Inventiva S.A.(IVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}